Molecular Biology
Recombinant DNA
DNA molecules combining sequences from different sources — basis of biotechnology
Recombinant DNA is DNA that contains sequences from two or more sources — combining genes that don't normally occur together. Created using restriction enzymes (cut DNA at specific sequences) and DNA ligase (joins fragments). First created 1973 (Boyer, Cohen) — milestone in biology. Foundation of biotechnology: recombinant proteins (insulin, growth hormone), gene therapy, GMOs, vaccines, research. Vehicles: plasmids (circular bacterial DNA), viral vectors. Issues: ethical, safety. Modern: cloning, gene editing (CRISPR), synthetic biology built on recombinant DNA principles.
- First createdBoyer and Cohen, 1973
- Restriction enzymesCut DNA at specific sequences (recognition sites)
- DNA ligaseJoins DNA fragments
- VectorsPlasmids, viral vectors, BACs, YACs
- First productRecombinant insulin (Humulin, 1982)
- ApplicationsTherapeutics, research, agriculture
Interactive visualization
Press play, or step through manually. The visualization is yours to drive — try it before reading on.
Watch the 60-second explainer
A condensed visual walkthrough — narrated, captioned, under a minute.
Why recombinant DNA matters
- Pharmaceutical. Insulin, growth hormone, vaccines.
- Gene therapy. Treating genetic diseases.
- Research. Studying gene function.
- Agriculture. Improved crops (Bt corn, Roundup-Ready).
- Diagnostics. DNA-based tests.
- Forensics. DNA fingerprinting.
- Industrial. Recombinant enzymes in detergents, food.
Common misconceptions
- Recombinant DNA = artificial. Process is artificial; resulting DNA is real.
- Bacteria can't accept human DNA. They readily transcribe/translate it.
- Recombinant proteins are different. Identical to natural protein in most cases.
- GMOs are dangerous. Safety record similar to traditional crops.
- CRISPR makes recombinant DNA obsolete. Different applications.
- One vector for all. Many vector systems for different uses.
Frequently asked questions
How is recombinant DNA made?
Steps. (1) Cut source DNA with restriction enzymes (cut at specific 4-8 bp sequences). (2) Cut vector with same enzyme — generates compatible "sticky ends" or "blunt ends." (3) Mix DNAs; ligase joins fragments via complementary ends. (4) Insert vector into host cell (transformation). (5) Select for cells with vector (antibiotic resistance). Result: cells expressing inserted gene.
What are restriction enzymes?
DNA-cutting enzymes from bacteria (originally bacterial defense against viruses). Each enzyme recognizes specific sequence (4-8 bp). Examples: EcoRI (GAATTC), HindIII (AAGCTT), BamHI (GGATCC). Cut at recognition site; some leave sticky ends (overhanging single strands), some blunt. Discovered 1970 (Smith, Nathans, Arber — Nobel 1978).
What's a plasmid vector?
Small circular DNA in bacteria; replicates independently. Engineered vectors: contain origin of replication (for replication), selectable marker (e.g., antibiotic resistance), multi-cloning site (where insert goes). Insert gene; transform into bacteria; select positive cells; grow large quantities. Foundation of cloning. Sizes: ~3-30 kb typical insert.
How is insulin made?
First commercial recombinant protein (1982). Process: human insulin gene cloned into plasmid; transformed into E. coli; bacteria express insulin protein; protein purified. Produced in vast quantities; treats diabetes worldwide. Before recombinant: insulin from pig pancreases — limited supply, immune issues. Recombinant: unlimited, identical to human insulin.
How is gene therapy delivered?
Vectors carry therapeutic gene to patient cells. Common: viral vectors (engineered viruses; deliver gene without causing disease). AAV (adeno-associated virus): popular, low immunogenicity, long expression. Lentivirus: integrates into genome; long-term expression. Approved: Kymriah (CAR-T cancer), Luxturna (eye disease). Challenges: safety, immune response, costs.
What about CRISPR vs recombinant DNA?
Different approaches. Recombinant DNA: introduces new sequences (insertions). CRISPR: edits existing sequences (insertions, deletions, replacements). Both: complementary tools. CRISPR more precise for editing; recombinant for adding completely new genes. Often used together: deliver CRISPR machinery via recombinant vector.
What ethical concerns exist?
Multiple. (1) GMOs (food): regulated; debated impact on health, environment. (2) Gene therapy: safety concerns (early trials had deaths). (3) Germline editing: heritable changes; CRISPR babies (He Jiankui, 2018) — widely condemned. (4) Bioweapons: dual-use research. (5) Patents on genes/organisms. Regulatory frameworks: NIH guidelines, FDA approval, international treaties.